14 - Maximizing Impact: Micro-ID Partnerships in Diagnostic Stewardship NGS Tests

Monday, October 20, 2025

8:00 AM - 9:00 AM US ET

Location: B401-B402

CME Credits: Maximum of 1 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1 hours of MOC Credit
CNE Credits: Maximum of 1 hours of ANCC Credit
ACPE Credits: ACPE 1 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

David Gaston, MD PhD

Assistant Professor, Medical Director (Molecular Infectious Disease Laboratory)
Vanderbilt University Medical Center
Nashville, TN, United States
Shangxin Yang, PhD, D(ABMM) (he/him/his)

Associate Clinical Professor, Laboratory Director
UCLA Department of Pathology and Laboratory Medicine
Univeristy of California, Los Angeles, Los Angeles, California, USA
Los Angeles, CA, United States

Faculty(s)

Ishminder Kaur, MD (she/her/hers)

Medical Director, Pediatric Antimicrobial Stewardship Program
Pediatric Antimicrobial Stewardship Program
Mattel Children's Hospital at UCLA
Los Angeles, CA, United States
Kathryn Goggin, MD MSc

Assistant Professor
Department of Pediatrics, Division of Infectious Diseases
Emory University School of Medicine and Children's Healthcare of Atlanta
Atlanta, GA, United States
MG

Mark Gonzalez, PhD

Director, Microbiology
Pathology
Children's Healthcare of Atlanta
Atlanta, GA, United States
Shangxin Yang, PhD, D(ABMM) (he/him/his)

Associate Clinical Professor, Laboratory Director
UCLA Department of Pathology and Laboratory Medicine
Univeristy of California, Los Angeles, Los Angeles, California, USA
Los Angeles, CA, United States

Disclosure(s):

David C. Gaston, MD PhD: American Society of Microbiology: Honoraria; Biomerieux/Biofire diagnositcs: Honoraria; DiaSorin: Honoraria; QuidelOrtho: Honoraria; Roche Diagnostics: Honoraria; T2Biosystems: Grant/Research Support

Shangxin Yang, PhD, D(ABMM): Eurofins | Viracor Clinical Diagnostics: Advisor/Consultant

Ishminder Kaur, MD: No financial relationships to disclose.

Kathryn P. Goggin, MD MSc: No financial relationships to disclose.

Mark D. Gonzalez, PhD: Biomerieux/Biofire diagnositcs: Advisor/Consultant

Learning Objectives:

At the conclusion of this session, participants will be able to:

explain how microbiology and infectious diseases partnerships can strengthen diagnostic stewardship of NGS tests;
identify algorithms to support appropriate utilization of NGS tests for infectious diseases;
define approaches to ensure appropriate interpretation of NGS tests to guide patient care.

Presentations:

8:00 AM - 8:15 AM US ET

Clinical Impact Of A Plasma Cell-Free DNA mNGS Test: The UCLA Experience
Speaker: Shangxin Yang, PhD, D(ABMM) (he/him/his) – Univeristy of California, Los Angeles, Los Angeles, California, USA
8:15 AM - 8:30 AM US ET

Real-World Clinical Impact of a Plasma Cell-Free DNA Test: The UCLA Experience
Speaker: Ishminder Kaur, MD (she/her/hers) – Mattel Children's Hospital at UCLA
8:30 AM - 8:45 AM US ET

Stewarding a Plasma Cell-Free DNA Test Among Pediatric Patients 1
Speaker: Mark D. Gonzalez, PhD – Children's Healthcare of Atlanta
8:45 AM - 9:00 AM US ET

Stewarding a Plasma Cell-Free DNA Test Among Pediatric Patients 2
Speaker: Kathryn P. Goggin, MD MSc – Emory University School of Medicine and Children's Healthcare of Atlanta